Department of Medicine, Division of Infectious Diseases and Immunology
Enterococcus faecalis; Vancomycin Resistance
Bacterial Infections and Mycoses | Epidemiology | Immunology and Infectious Disease | Microbiology
We read the article of Hayakawa et al with great interest. The report describes the growing prevalence of vancomycin-resistant Enterococcus faecalis in Michigan, a state that also has the most reports of vancomycin-resistant Staphylococcus aureus. Similar findings were reported in the tigecycline evaluation and surveillance trial (TEST). During the 2004–2009 period, 4.6% of 3,753 E. faecalis isolates were vancomycin resistant, with the highest rates of 7.6% in the East North Central region of United States. Here we report rates and trends of vancomycin-resistant E. faecalis in the East North Central region compared with national rates from 1999 to 2010.
Rights and Permissions
Publisher PDF posted as allowed by the publisher's author rights policy at http://www.press.uchicago.edu/journals/jrnl_rights.html#faq4.
DOI of Published Version
Gandra S, Braykov N, Laxminarayan R. East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States. Infect Control Hosp Epidemiol. 2013 Apr;34(4):443-5. doi: 10.1086/669872. Link to article on publisher's site
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America
Gandra, Sumanth; Braykov, Nikolay; and Laxminarayan, Ramanan, "East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States" (2013). University of Massachusetts Medical School Faculty Publications. 112.